Literature DB >> 33567691

Development of a Liquid Chromatography/Mass Spectrometry-Based Inhibition Assay for the Screening of Steroid 5-α Reductase in Human and Fish Cell Lines.

Dahye Kim1, Hyunki Cho1, Ruth Eggers1, Sang Kyum Kim2, Chang Seon Ryu1, Young Jun Kim1,3.   

Abstract

Steroid 5-α reductase (5AR) is responsible for the reduction of steroids to 5-α reduced metabolites, such as the reduction of testosterone to 5-α dihydrotestosterone (DHT). A new adverse outcome pathway (AOP) for 5AR inhibition to reduce female reproduction in fish (AOP 289) is under development to clarify the antiestrogenic effects of 5AR inhibitors in female fish. A sensitive method for the DHT analysis using chemical derivatization and liquid chromatography-tandem mass spectrometry was developed. A cell-based 5AR inhibition assay that utilizes human cell lines, a transient overexpression system, and fish cell lines was developed. The measured IC50 values of two well-known 5AR inhibitors, finasteride and dutasteride, were comparable in the different systems. However, the IC50 of dutasteride in the fish cell lines was lower than that in the human cell lines. Finasteride showed a higher IC50 against the RTG-2 cell line. These results demonstrated that 5ARs inhibition could differ in terms of structural characteristics among species. The assay has high sensitivity and reproducibility and is suitable for the application in 5AR inhibition screening for various endocrine disruption chemicals (EDCs). Future studies will continue to evaluate the quantitative inhibition of 5AR by EDCs to compare the endocrine-disrupting pathway in different species.

Entities:  

Keywords:  5α-reductase inhibitors; adverse outcome pathway; dihydrotestosterone; dutasteride; finasteride; in vitro

Mesh:

Substances:

Year:  2021        PMID: 33567691      PMCID: PMC7915527          DOI: 10.3390/molecules26040893

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  46 in total

1.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

2.  Identification and quantification of 5α-dihydrotestosterone in the teleost fathead minnow (Pimephales promelas) by gas chromatography-tandem mass spectrometry.

Authors:  Luigi Margiotta-Casaluci; Frédérique Courant; Jean-Philippe Antignac; Bruno Le Bizec; John P Sumpter
Journal:  Gen Comp Endocrinol       Date:  2013-07-04       Impact factor: 2.822

3.  Inverse Regulation of DHT Synthesis Enzymes 5α-Reductase Types 1 and 2 by the Androgen Receptor in Prostate Cancer.

Authors:  Étienne Audet-Walsh; Tracey Yee; Ingrid S Tam; Vincent Giguère
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

4.  The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

Authors:  John D McConnell; Claus G Roehrborn; Oliver M Bautista; Gerald L Andriole; Christopher M Dixon; John W Kusek; Herbert Lepor; Kevin T McVary; Leroy M Nyberg; Harry S Clarke; E David Crawford; Ananias Diokno; John P Foley; Harris E Foster; Stephen C Jacobs; Steven A Kaplan; Karl J Kreder; Michael M Lieber; M Scott Lucia; Gary J Miller; Mani Menon; Douglas F Milam; Joe W Ramsdell; Noah S Schenkman; Kevin M Slawin; Joseph A Smith
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

5.  Current perspectives on the androgen 5 alpha-dihydrotestosterone (DHT) and 5 alpha-reductases in teleost fishes and amphibians.

Authors:  Christopher J Martyniuk; Sonja Bissegger; Valérie S Langlois
Journal:  Gen Comp Endocrinol       Date:  2013-10-03       Impact factor: 2.822

6.  In vivo steroid regulation of aromatase and 5 alpha-reductase in goldfish brain and pituitary.

Authors:  M Pasmanik; B A Schlinger; G V Callard
Journal:  Gen Comp Endocrinol       Date:  1988-07       Impact factor: 2.822

7.  Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.

Authors:  A R Diani; M J Mulholland; K L Shull; M F Kubicek; G A Johnson; H J Schostarez; M N Brunden; A E Buhl
Journal:  J Clin Endocrinol Metab       Date:  1992-02       Impact factor: 5.958

8.  Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.

Authors:  Bo-Ying Bao; Bin-Fay Chuang; Qianben Wang; Oliver Sartor; Steven P Balk; Myles Brown; Philip W Kantoff; Gwo-Shu Mary Lee
Journal:  Prostate       Date:  2008-06-01       Impact factor: 4.104

9.  Bioactives in Chinese Proprietary Medicine Modulates 5α-Reductase Activity and Gene Expression Associated with Androgenetic Alopecia.

Authors:  Justin J Y Tan; Jing Pan; Lihan Sun; Junying Zhang; Chunyong Wu; Lifeng Kang
Journal:  Front Pharmacol       Date:  2017-04-13       Impact factor: 5.810

10.  Identification of a new plant extract for androgenic alopecia treatment using a non-radioactive human hair dermal papilla cell-based assay.

Authors:  Ruchy Jain; Orawan Monthakantirat; Parkpoom Tengamnuay; Wanchai De-Eknamkul
Journal:  BMC Complement Altern Med       Date:  2016-01-21       Impact factor: 3.659

View more
  1 in total

1.  Antioxidation, Anti-Inflammation, and Regulation of SRD5A Gene Expression of Oryza sativa cv. Bue Bang 3 CMU Husk and Bran Extracts as Androgenetic Alopecia Molecular Treatment Substances.

Authors:  Chiranan Khantham; Pichchapa Linsaenkart; Tanakarn Chaitep; Pensak Jantrawut; Chuda Chittasupho; Pornchai Rachtanapun; Kittisak Jantanasakulwong; Yuthana Phimolsiripol; Sarana Rose Sommano; Chanakan Prom-U-Thai; Sansanee Jamjod; Chaiwat Arjin; Korawan Sringarm; Houda Berrada; Francisco J Barba; Francisco David Carmona; Wutigri Nimlamool; Warintorn Ruksiriwanich
Journal:  Plants (Basel)       Date:  2022-01-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.